| Literature DB >> 35163945 |
Qian Gao1, Zongmin Wei2,3, Yun Liu1, Fang Wang1, Shuting Zhang1, Carmo Serrano4, Lingxi Li1, Baoshan Sun1,5.
Abstract
Moringa oleifera leaves have been widely used for the treatment of inflammation, diabetes, high blood pressure, and other diseases, due to being rich in polyphenols. The main objective of this work was to largely separate the main polyphenols from Moringa oleifera leaves using the technique of high-speed counter-current chromatography (HSCCC). The phenolic composition in Moringa oleifera leaves was first analyzed qualitatively and quantitatively by UPLC-Q-Exactive Orbitrap/MS and UPLC-QqQ/MS, respectively, indicating that quercetin and kaempferol derivatives, phenolic acid and apigenin are the main polyphenols in Moringa oleifera leaves, with quercetin and kaempferol derivatives predominating. Furthermore, the conditions of HSCCC for large-scale separation of polyphenols from Moringa oleifera leaves were optimized, which included the selection of the solvent system, flow rate and the sample load. Only by one-step HSCCC separation (within 120 min) under the optimized conditions, six quercetin and kaempferol derivatives, a phenolic acid and an apigenin could be individually isolated at a large scale (yield from 10% to 98%), each of which possessed high purity. Finally, the isolated polyphenols and phenolic extract from Moringa oleifera leaves (MLPE) were verified to have strong neuroprotective activities against H2O2-induced oxidative stress in PC-12 cells, suggesting that these compounds would contribute to the main beneficial effects of Moringa oleifera leaves.Entities:
Keywords: Moringa oleifera leaf; high-speed countercurrent chromatography; kaempferol; neuroprotective effects; polyphenols; quercetin
Mesh:
Substances:
Year: 2022 PMID: 35163945 PMCID: PMC8840448 DOI: 10.3390/molecules27030678
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
MRM parameters, cone voltage (CV) and collision energy (CE) for each standard measured.
| Standards/Equivalent Compounds | Precursor Ion | Product Ion | Fragmentor | Collision Energy | Polarity |
|---|---|---|---|---|---|
| 4-Caffeoylquinic acid | 353.2 | 173.2 | 120 | 15 | Negative |
| Vitexin | 431.2 | 311.1 | 200 | 20 | Negative |
| Rutin | 609.2 | 300.1 | 270 | 36 | Negative |
| Isoquercitrin | 463.1 | 300.1 | 200 | 24 | Negative |
| Kaempferol-3-O-rutinoside | 593.2 | 285.2 | 230 | 35 | Negative |
| Astragalin | 447.1 | 284.1 | 210 | 28 | Negative |
| Quercetin-acetyl-glycoside | 505.2 | 300.1 | 200 | 25 | Negative |
| Kaempferol-malonyl-glycoside | 533.1 | 489.2 | 150 | 5 | Negative |
List of tentative compounds identified in Moringa oleifera leaves by UPLC-Q-Exactive-MS/MS under negative ionization.
| No. | Compounds | tR/min | [M–H]− | MS/MS | Theoretical Mass | Error (ppm) | Formula |
|---|---|---|---|---|---|---|---|
| 1 | Caffeic acid | 0.53 | 178.9769 | 89.0228/161.0444 | 180.0422 | −0.82 | C9H8O4 |
| 2 | Quinic acid | 0.66 | 190.9276 | 85.0278/127.0387 | 192.0633 | −0.90 | C7H12O6 |
| 3 | Malic acid | 0.73 | 133.0129 | 115.0022/71.0122 | 134.0215 | −0.31 | C4H6O5 |
| 4 | Glucomoringin | 0.92 | 570.0964 | 96.9585/259.0131 | 571.1029 | −2.58 | C20H29NO14S2 |
| 5 | Vanillin glucoside | 1.48 | 315.0724 | 153.0545/108.0201 | 316.1158 | −0.82 | C14H20O8 |
| 6 | 4-Caffeoylquinic acid | 1.63 | 353.0880 | 191.0552/179.0340 | 354.0951 | −0.45 | C16H18O9 |
| 7 | Vanillin glucoside | 2.01 | 315.0724 | 153.0545/123.0438 | 316.1158 | −0.72 | C14H20O8 |
| 8 | 3-Caffeoylquinic acid | 2.34 | 353.0880 | 191.0552/179.0340 | 354.0951 | 0.51 | C16H18O9 |
| 9 | 4-Coumaroylquinic acid | 3.16 | 337.0931 | 163.0389/119.0488 | 338.1002 | −1.57 | C16H18O8 |
| 10 | 3-Coumaroylquinic acid | 3.68 | 337.0931 | 163.0389/119.0488 | 338.1002 | 2.94 | C16H18O8 |
| 11 | Feruloylquinic acid | 4.74 | 367.1036 | 193.0498/134.0359 | 368.1107 | 1.10 | C17H20O9 |
| 12 | Vicenin-2 | 6.74 | 593.1516 | 353.0668/383.0775 | 594.1585 | −0.53 | C27H30O15 |
| 13 | Vitexin | 8.52 | 431.0984 | 311.0563/341.0666 | 432.1056 | 0.14 | C21H20O10 |
| 14 | Rutin | 8.62 | 609.1464 | 300.0276/343.0455 | 610.1534 | 1.02 | C27H30O16 |
| 15 | Isoquercitrin | 8.76 | 463.0887 | 300.0276/343.0464 | 464.0955 | −0.99 | C21H20O12 |
| 16 | Quercetin-acetyl-glycoside | 9.41 | 505.0993 | 300.0276/343.0455 | 506.1060 | −0.32 | C23H22O13 |
| 17 | Quercetin-malonyl-glucoside | 9.41 | 549.0888 | 300.0276 | 550.0959 | −1.06 | C24H22O15 |
| 18 | Kaempferol-3-O-rutinoside | 9.52 | 593.1516 | 285.0405/327.0510 | 594.1585 | −0.53 | C27H30O15 |
| 19 | Isolariciresinol glucoside | 9.53 | 521.2034 | 341.1398/101.0228 | 522.2101 | 0.91 | C26H34O11 |
| 20 | Astragalin | 9.88 | 447.0936 | 284.0327/327.0513 | 448.1006 | −0.20 | C21H20O11 |
| 21 | Kaempferol-acetyl-glycoside | 10.7 | 489.1042 | 284.0328/327.0495 | 490.1111 | −0.43 | C23H22O12 |
| 22 | Kaempferol-malonyl-glycoside | 10.7 | 533.1724 | 285.0404/255.0295 | 534.1010 | 1.16 | C24H22O14 |
Calibration curve, LOD and LOQ of standards.
| Compounds | Regression Equation | r | Linear Range | LOD | LOQ |
|---|---|---|---|---|---|
| 4-Caffeoylquinic acid | y = 2.384x + 0.1378 | 0.9993 | 6.413–410.4 | 0.05388 | 0.1796 |
| Vitexin | y = 10.70x + 0.0285 | 0.9996 | 0.2775–17.76 | 0.01281 | 0.04271 |
| Rutin | y = 6.293x + 0.0261 | 0.9993 | 0.7950–50.88 | 0.02228 | 0.07425 |
| Isoquercitrin | y = 9.22x + 0.1726 | 0.9995 | 1.500–96.0 | 0.01488 | 0.04959 |
| Kaempferol-3-O-rutinoside | y = 2.630x + 0.0231 | 0.9997 | 0.5450–34.88 | 0.05225 | 0.1742 |
| Astragalin | y = 11.86x + 0.1738 | 0.9991 | 0.4538–29.04 | 0.01046 | 0.03486 |
Precision, repeatability and stability of standards.
| Compounds | Precision (%) | Repeatability | Stability | |
|---|---|---|---|---|
| Intra-Day RSD | Inter-Day RSD | RSD (%) | RSD (%) | |
| 4-Caffeoylquinic acid | 2.9 | 3.4 | 2.5 | 3.4 |
| Vicenin-2 | 1.5 | 1.1 | 0.6 | 0.9 |
| Vitexin | 3.6 | 3.8 | 2.3 | 2.3 |
| Rutin | 0.3 | 0.3 | 0.4 | 4.8 |
| Isoquercitrin | 0.03 | 0.1 | 0.5 | 3.4 |
| Kaempferol-3-O-rutinoside | 0.6 | 0.8 | 4.8 | 4.6 |
| Astragalin | 1.1 | 1.1 | 1.2 | 2.9 |
Recoveries of compounds in MLPE (n = 6).
| Compounds | Initial Amount | Added Amount | Detected Amount | Recovery | RSD |
|---|---|---|---|---|---|
| 4-Caffeoylquinic acid | 1.045 | 1.054 | 2.032 | 96.8 | 2.1 |
| 1.048 | 1.054 | 2.060 | 98.0 | ||
| 1.043 | 1.054 | 2.021 | 96.4 | ||
| 1.046 | 1.054 | 2.016 | 96.0 | ||
| 1.046 | 1.054 | 2.132 | 101.5 | ||
| 1.043 | 1.054 | 2.049 | 97.7 | ||
| Vitexin | 0.1693 | 0.1884 | 0.3410 | 95.3 | 4.1 |
| 0.1708 | 0.1884 | 0.3769 | 104.9 | ||
| 0.1650 | 0.1884 | 0.3382 | 95.7 | ||
| 0.1710 | 0.1884 | 0.3537 | 98.4 | ||
| 0.1691 | 0.1884 | 0.3679 | 102.9 | ||
| 0.1673 | 0.1884 | 0.3425 | 96.3 | ||
| Rutin | 1.244 | 1.271 | 2.484 | 98.8 | 1.9 |
| 1.258 | 1.271 | 2.519 | 99.6 | ||
| 1.195 | 1.271 | 2.396 | 97.2 | ||
| 1.212 | 1.271 | 2.405 | 96.9 | ||
| 1.218 | 1.271 | 2.541 | 102.1 | ||
| 1.245 | 1.271 | 2.493 | 99.1 | ||
| Isoquercitrin | 1.145 | 1.190 | 2.387 | 102.2 | 2.5 |
| 1.178 | 1.190 | 2.337 | 98.7 | ||
| 1.126 | 1.190 | 2.218 | 95.8 | ||
| 1.140 | 1.190 | 2.242 | 96.2 | ||
| 1.145 | 1.190 | 2.276 | 97.5 | ||
| 1.158 | 1.190 | 2.266 | 96.5 | ||
| Kaempferol-3-O-rutinoside | 0.6031 | 0.6099 | 1.236 | 101.9 | 3.2 |
| 0.6018 | 0.6099 | 1.183 | 97.6 | ||
| 0.5125 | 0.6099 | 1.159 | 103.3 | ||
| 0.5366 | 0.6099 | 1.128 | 98.4 | ||
| 0.5578 | 0.6099 | 1.112 | 95.2 | ||
| 0.5744 | 0.6099 | 1.141 | 96.3 | ||
| Astragalin | 0.1741 | 0.1848 | 0.3733 | 104.0 | 3.9 |
| 0.1804 | 0.1848 | 0.3552 | 97.3 | ||
| 0.1736 | 0.1848 | 0.3712 | 103.6 | ||
| 0.1769 | 0.1848 | 0.3443 | 95.2 | ||
| 0.1742 | 0.1848 | 0.3519 | 98.0 | ||
| 0.1788 | 0.1848 | 0.3477 | 95.6 |
Contents of 10 polyphenolic compounds in MLPE.
| Compounds | tR(min) | Contents (mg/g DW) |
|---|---|---|
| 4-Caffeoylquinic acid | 3.7 | 1.985 ± 0.008 |
| Vitexin | 7.8 | 0.3415 ± 0.005 |
| Rutin | 7.9 | 2.267 ± 0.006 |
| Isoquercitrin | 8.2 | 2.293 ± 0.005 |
| Quercetin-acetyl-glycoside | 9.1 | 2.456 ± 0.004 |
| Kaempferol-3-O-rutinoside | 9.3 | 1.206 ± 0.003 |
| Astragalin | 9.6 | 0.4007 ± 0.002 |
| Kaempferol-malonyl-glycoside | 10.8 | 0.1254 ± 0.003 |
Partition coefficient values (K) and separation factors (α) of six solvent systems.
| Solvent Systems ( | Isoquercitrin ( | Astragalin ( | α |
|---|---|---|---|
| HEMWat (1:20:2:20, | 1.00 | 1.17 | 1.17 |
| H2O-hexane- ethyl acetate (50:1:50, | 2.20 | 106.9 | - |
| HEMWat (1:5:1:5, | 1.01 | 0.79 | 1.28 |
| HEMWat (1:3:1:3, | 1.01 | 0.77 | 1.31 |
| HEMWat (3:5:3:5, | 1.01 | 54.49 | - |
| HEMWat (1:1:1:1, | 1.00 | 28.55 | - |
Figure 1HSCCC chromatograms of preparative separation of polyphenols from MPLE under the optimized conditions, and four components were separated into A, B, C and D.
Figure 2UPLC–MS analysis of Fractions (A–D) and MS identification of individual polyphenols. Fraction (A): peak 1, 4-caffeoylquinic acid; peak 2, rutin; peak 3, isoquercitrin; peak 4, quercetin-acetyl-glycoside; peak 5, kaempferol-3-o-rutinoside. Fraction (B): peak 6, vitexin; peak 7, isoquercitrin; peak 8, astragalin; peak 9, kaempferol-malonyl-glycoside. Fraction (C): peak 10, isoquercitrin. Fraction (D): peak 11, astragalin.
Retention time (TR) of individual polyphenols and their major ions observed in the MS/MS spectra.
| No. | TR (min) | [M–H]− | MS/MS | Formula | Compounds |
|---|---|---|---|---|---|
| 1 | 3.7 | 353.0880 | 191.0552/179.0340 | C16H18O9 | 4-Caffeoylquinic acid |
| 2 | 7.9 | 609.1464 | 300.0276 | C27H30O16 | Rutin |
| 3 | 9.1 | 505.0993 | 300.0276 | C23H22O13 | Quercetin-acetyl-glycoside |
| 4 | 9.2 | 593.1516 | 285.0405 | C27H30O15 | Kaempferol-3-O-rutinoside |
| 5 | 7.7 | 431.0984 | 311.0563/341.0666 | C21H20O10 | Vitexin |
| 6 | 8.2 | 463.0887 | 300.0276 | C21H20O12 | Isoquercitrin |
| 7 | 9.5 | 447.0936 | 284.0327/255.0300 | C21H20O11 | Astragalin |
| 8 | 10.8 | 533.1724 | 285.0404 | C24H22O14 | Kaempferol-malonyl-glycoside |
Figure 3Effect of individual compounds and MLPE on cell viability of PC-12 cells. Cells were pretreated with individual compounds and MLPE for 12 h. Cell viability was assessed by MTT.
Figure 4Effect of H2O2 on cell viability of PC-12 cells. Cells were treated with different concentrations of H2O2 for 12 h and cell viability was assessed by MTT. *** p < 001 vs. control group.
Figure 5Effect of individual compounds and MLPE on cell viability of H2O2-induced PC-12 cells. Cells were pretreated with individual compounds and MLPE for 12 h and then treated with H2O2 (800 µM) for 12 h. Cell viability was assessed by MTT. ### p < 0.001 versus control group; * p < 0.05, ** p < 0.01, and *** p < 0.001 vs. H2O2 group.